跳至主要内容
临床试验/NL-OMON21605
NL-OMON21605招募中不适用

Validation of a new fibrinolysis assay for thrombelastometry on the ROTEM® device

MUMC+0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • The population consist of all in hospital adult (= 18 years old) patients at the Maastricht University Medical Centre. 20-30 patients of each group will be asked informed consent for blood withdrawal for this in vitro measurement on the ROTEM® device.
  • The population consist of the following patient groups:
  • - Sepsis (with/without DIC)
  • - Liver impairment (Child-Pugh A/B/C)
  • - Patientgroups in which an altered hemostatic balance can be expected, like patients treated for hematological malignancies who have severe thrombocytopenia

排除标准

  • temperature >38,0°C, sepsis, active bleeding, splenomegaly or use of anticoagulation medication.

研究者

发起方
MUMC+

相似试验